Clinical trial
Evaluating the Impact of Energy Drink Formulas on Alertness for an Extended Period
NCT07400614 is registered in ClinicalTrials.gov with PepsiCo Global R&D as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Impact of Energy Drink Formulas on Alertness for an Extended Period
- Lead sponsor
- PepsiCo Global R&D
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 26, 2026
- Completion date
- June 30, 2026
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alertness